PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine B, Assuta Ashdod Medical Center, Ashdod, Israel, affiliated with Ben-Gurion University of the Negev.\', \'Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\', \'Department of Internal Medicine T, Sheba Medical Center, Tel-Hashomer, Israel.\', \'Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.\', \'Department of Internal Medicine B, Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.\', \'Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Israel.\', \'Department of Rheumatology, Assuta Ashdod Medical Center, Ashdod, Israel, affiliated with Ben-Gurion University of the Negev.\']
?:citedBy
  • -1
?:creator
?:hasPublicationType
?:journal
  • The Israel Medical Association journal : IMAJ
is ?:pmid of
?:pmid
?:pmid
  • 33236582
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Ferritin as a Marker of Severity in COVID-19 Patients: A Fatal Correlation.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all